Promising therapies: TOT, duloxetine, botulinum A

• Burch versus sling in 650 women with stress incontinence; performed by the Urinary Incontinence Treatment Network (an NIH-funded network of 9 clinical sites).
  
• Burch versus no Burch in 480 women without stress incontinence symptoms with advanced prolapse undergoing abdominal sacral colpopexy; performed by the Pelvic Floor Disorders Network (an NIH-funded network of 7 clinical sites).
  

A reminder: Inform the patient

We all want better results of surgical treatment in our patients and, to accomplish that, we need surgical experimentation, which I wholeheartedly support. But such research must be carried out with the patient’s knowledge that she is receiving new and experimental therapy. To do otherwise is unethical.

Dr. Weber serves as an NIH consultant, and reports no other financial relationships in any other capacity.